ArticleBMJ open2016
Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies' websites.
Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Industry funding of patient and health consumer organisations: systematic review with meta-analysis.BMJ (Clinical research ed.) · 2020Pooled it
- Evaluating conflict-of-interest governance among Canadian medical societies using a novel assessment tool: A cross-sectional study.PloS one · 2026Article
- Commercial influences on patient and public involvement: a renewed call for research and action.Health promotion international · 2024Article
- Seeking to be seen as legitimate members of the scientific community? An analysis of British American Tobacco and Philip Morris International's involvement in scientific events.Tobacco control · 2024Article
- Key issues for stakeholder engagement in the development of health and healthcare guidelines.Research involvement and engagement · 2023Article
- Sponsorship of Canadian Professional Medical Societies by Drug, Medical Device and Medical Technology Companies: a Cross-sectional Study.Journal of general internal medicine · 2022Article
- Sponsorship of Australian and New Zealand medical societies by healthcare companies: an observational study.JRSM open · 2022Article
- Review
- 'Public health nutrition · 2021Article
- Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.International urogynecology journal · 2021Article
- Review
- Identifying competing interest disclosures in systematic reviews of surgical interventions and devices: a cross-sectional survey.BMC medical research methodology · 2020Article
- Conflicts of interest and Scientific Societies.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020Review
- [Conflicts of interest in the medical profession].Atencion primaria · 2019Article
- Article
- Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015.JAMA network open · 2019Observational
- Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan.JAMA internal medicine · 2019Article
- Professional medical societies: do we have any conflict of interest with industry?Intensive care medicine · 2018Article
- Article
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo describe how Italian medical societies interact with pharmaceutical and medical device industries through an analysis of the information available on their websites.
designCross sectional study.
settingItaly.
participants154 medical societies registered with the Italian Federation of Medical-Scientific Societies.
main outcome measuresIndicators of industry sponsorship (presence of industry sponsorship in the programme of the last medical societies' annual conference; presence of manufacturers' logos on the homepage; presence of industry sponsorship of satellite symposia during the last annual conference).
results131 Italian medical societies were considered. Of these, 4.6% had an ethical code covering relationships with industry on their websites, while 45.6% had a statute that mentioned the issue of conflict of interest and 6.1% published the annual financial report. With regard to industry sponsorship, 64.9% received private sponsorship for their last conference, 29.0% had manufacturers' logos on their webpage, while 35.9% had industry-sponsored satellite symposia at their last conference. The presence of an ethical code on the societies' websites was associated with both an increased risk of industry sponsorship of the last conference (relative risk (RR) 1.22, 95% CIs 1.01 to 1.48 after adjustment) and of conferences and/or satellite symposia (RR 1.22, 95% CIs 1.02 to 1.48 after adjustment) but not with the presence of manufacturers' logos on the websites (RR 1.79, 95% CIs 0.66 to 4.82 after adjustment). No association was observed with the other indicators of governance and transparency.
conclusionsThis survey shows that industry sponsorship of Italian medical societies' conferences is common, while the presence of a structured regulatory system is not. Disclosure of the amount of industry funding to medical societies is scarce. The level of transparency therefore needs to be improved and the whole relationship between medical societies and industry should be further disciplined in order to avoid any potential for conflict of interest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.